XFOR
X4 Pharmaceuticals, IncCompany with tickers: XFOR
CIK
1501697
CUSIP
98420X202
Shares Outstanding
94,319,696
13F Activity (30d)
59 filings
58 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2022-05-12 | — | |
| 8-K | 2022-05-20 | — | |
| 8-K | 2022-06-07 | 2022-06-06 | |
| 8-K | 2022-07-01 | 2022-06-30 | |
| 8-K | 2022-07-29 | 2022-07-25 | |
| 10-Q | 2022-08-04 | 2022-06-30 | |
| 8-K | 2022-08-04 | — | |
| 8-K | 2022-08-05 | — | |
| 8-K | 2022-09-01 | — | |
| 8-K | 2022-09-27 | — | |
| 8-K | 2022-10-04 | — | |
| 8-K | 2022-11-03 | — | |
| 10-Q | 2022-11-03 | 2022-09-30 | |
| 8-K | 2022-11-09 | 2022-11-07 | |
| 8-K | 2022-11-29 | — | |
| 8-K | 2022-12-09 | 2022-12-06 | |
| 8-K | 2022-12-23 | 2022-12-20 | |
| 8-K | 2023-01-05 | — | |
| 8-K | 2023-01-06 | — | |
| 8-K | 2023-03-10 | — | |
| 10-K | 2023-03-21 | 2022-12-31 | |
| 8-K | 2023-03-21 | — | |
| 8-K | 2023-05-04 | — | |
| 10-Q | 2023-05-04 | 2023-03-31 | |
| 8-K | 2023-05-16 | 2023-05-15 | |
| 8-K | 2023-06-01 | — | |
| 8-K | 2023-06-15 | 2023-06-13 | |
| 8-K | 2023-08-03 | 2023-08-02 | |
| 8-K | 2023-08-10 | — | |
| 10-Q | 2023-08-10 | 2023-06-30 | |
| 8-K | 2023-09-05 | — | |
| 8-K | 2023-10-18 | 2023-10-16 | |
| 8-K | 2023-10-31 | — | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-11-09 | — | |
| 8-K | 2023-11-14 | 2023-11-13 | |
| 8-K | 2023-11-27 | — | |
| 8-K | 2024-01-08 | — | |
| 10-K | 2024-03-21 | 2023-12-31 | |
| 8-K | 2024-03-21 | — | |
| 8-K | 2024-04-01 | — | |
| 8-K | 2024-04-05 | — | |
| 8-K | 2024-04-29 | — | |
| 8-K | 2024-05-07 | — | |
| 10-Q | 2024-05-07 | 2024-03-31 | |
| 8-K | 2024-05-09 | 2024-05-08 | |
| 8-K | 2024-05-22 | — | |
| 8-K | 2024-06-11 | 2024-06-10 | |
| 8-K | 2024-06-27 | — | |
| 8-K | 2024-07-19 | — |
Showing 51–100 of 129 filings